Cargando…

Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study

BACKGROUND: Aripiprazole is a second-generation antipsychotic, efficacious in patients with schizophrenia during acute episodes. Due to its pharmacological profile, aripiprazole may be of interest in patients with specific clinical profiles who have not been studied extensively in randomised clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Llorca, Pierre-Michel, Nuss, Philippe, Fakra, Éric, Alamome, Isabelle, Drapier, Dominique, Hage, Wissam El, Jardri, Renaud, Mouchabac, Stéphane, Rabbani, Marc, Simon, Nicolas, Vacheron, Marie-Noëlle, Azorin, Jean-Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142729/ https://www.ncbi.nlm.nih.gov/pubmed/35643542 http://dx.doi.org/10.1186/s12888-022-04008-9

Ejemplares similares

Neural correlates of delusional infestation responding to aripiprazole monotherapy: a case report
por: Ponson, Laura, et al.
Publicado: (2015)

Examining transcranial random noise stimulation as an add-on treatment for persistent symptoms in schizophrenia (STIM’Zo): a study protocol for a multicentre, double-blind, randomized sham-controlled clinical trial
por: Brunelin, Jerome, et al.
Publicado: (2021)

TARC: Turkish aripiprazole consensus report- Aripiprazole use and switching from other antipsychotics to aripiprazole- consensus recommendations by a Turkish multidisciplinary panel
por: Veznedaroglu, Baybars, et al.
Publicado: (2018)

e-PTSD: an overview on how new technologies can improve prediction and assessment of Posttraumatic Stress Disorder (PTSD)
por: Bourla, Alexis, et al.
Publicado: (2018)

Binding kinetics of cariprazine and aripiprazole at the dopamine D(3) receptor
por: Frank, Annika, et al.
Publicado: (2018)

Dopamine supersensitivity psychosis and dopamine partial agonist: A retrospective survey of failure of switching to aripiprazole in schizophrenia
por: Takase, Masayuki, et al.
Publicado: (2015)

Chronic Treatment With Aripiprazole Prevents Development of Dopamine Supersensitivity and Potentially Supersensitivity Psychosis
por: Tadokoro, Shigenori, et al.
Publicado: (2012)

Place in therapy of innovative drugs in multiple myeloma in 2021 and 2023 according to an expert panel Delphi consensus
por: Mario, Boccadoro, et al.
Publicado: (2021)

Good Clinical Approach: Delphi Consensus for the Use of Betahistine in Menière's Disease
por: Casani, Augusto Pietro, et al.
Publicado: (2018)

Behavioral Mechanisms That Depend on Dopamine and Serotonin in Caenorhabditis elegans Interact With the Antipsychotics Risperidone and Aripiprazole
por: Osuna-Luque, Jaime, et al.
Publicado: (2018)

Repetitive Transcranial Magnetic Stimulation (rTMS) in Post-Traumatic Stress Disorder: Study Protocol of a Nationwide Randomized Controlled Clinical Trial of Neuro-Enhanced Psychotherapy “TraumaStim”
por: Ferreri, Florian, et al.
Publicado: (2023)

Decrease in tobacco consumption after treatment with topiramate and aripiprazole: a case report
por: Arbaizar, Beatriz, et al.
Publicado: (2008)

Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism
por: de Bartolomeis, Andrea, et al.
Publicado: (2015)

Dopamine receptor D(2) activation suppresses the radiosensitizing effect of aripiprazole via activation of AMPK
por: Lee, Hyounji, et al.
Publicado: (2019)

Discovery research and development history of the dopamine D(2) receptor partial agonists, aripiprazole and brexpiprazole
por: Kikuchi, Tetsuro, et al.
Publicado: (2021)

Case report: Open bite as an extrapyramidal side effect with aripiprazole, a dopamine partial agonist
por: Sumi, Satoko, et al.
Publicado: (2022)

A Case of Aripiprazole-Induced Tardive Dyskinesia with Dramatic Evolution
por: Heitzmann, Edwige, et al.
Publicado: (2016)

Taiwan Expert Consensus Recommendations for Switching to Aripiprazole Long-Acting Once-Monthly in Patients with Schizophrenia
por: Liang, Chih-Sung, et al.
Publicado: (2021)

Neurocognitive disorders: what are the prioritized caregiver needs? A consensus obtained by the Delphi method
por: Novais, Teddy, et al.
Publicado: (2018)

Biological conversion of aripiprazole lauroxil - An N-acyloxymethyl aripiprazole prodrug
por: Rohde, Morten, et al.
Publicado: (2014)

Chlorine Atoms of an Aripiprazole Molecule Control the Geometry and Motion of Aripiprazole and Deschloro-aripiprazole in Subdomain IIIA of Human Serum Albumin
por: Kawai, Akito, et al.
Publicado: (2022)

Consensus Definition of Misophonia: A Delphi Study
por: Swedo, Susan E., et al.
Publicado: (2022)

Developing consensus in Histopathology: the role of the Delphi method
por: Taze, Dilek, et al.
Publicado: (2022)

A Delphi consensus statement for digital surgery
por: Lam, Kyle, et al.
Publicado: (2022)

Measuring multimorbidity in research: Delphi consensus study
por: Ho, Iris S S, et al.
Publicado: (2022)

Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review
por: Grall-Bronnec, Marie, et al.
Publicado: (2016)

Association between cannabis use and symptoms of psychosis: a mega-analysis
por: Argote, M., et al.
Publicado: (2023)

Effects of Dopamine D(2) Receptor Partial Agonist Antipsychotic Aripiprazole on Dopamine Synthesis in Human Brain Measured by PET with L-[β-(11)C]DOPA
por: Ito, Hiroshi, et al.
Publicado: (2012)

Aripiprazole cardiosafety: Is it overestimated?
por: Naguy, Ahmed
Publicado: (2016)

Aripiprazole-induced priapism
por: Trivedi, Satya K., et al.
Publicado: (2016)

The relationship between dopamine receptor blockade and cognitive performance in schizophrenia: a [(11)C]-raclopride PET study with aripiprazole
por: Shin, Sangho, et al.
Publicado: (2018)

International Multispecialty Consensus on How to Evaluate Ultrasound Competence: A Delphi Consensus Survey
por: Tolsgaard, Martin G., et al.
Publicado: (2013)

Inhaled treatment of COPD: a Delphi consensus statement
por: Ninane, Vincent, et al.
Publicado: (2017)

Optimization of the Therapeutic Approach to Patients with Sarcoma: Delphi Consensus
por: Álvarez Álvarez, Rosa, et al.
Publicado: (2019)

Oligomeric Formulas in Surgery: A Delphi and Consensus Study
por: De Luis Román, Daniel, et al.
Publicado: (2021)

A Malaysian Delphi consensus on managing knee osteoarthritis
por: Yeap, Swan Sim, et al.
Publicado: (2021)

Agonist and Antagonist Effects of Aripiprazole on D(2)-Like Receptors Controlling Rat Brain Dopamine Synthesis Depend on the Dopaminergic Tone
por: Ma, Guo Fen, et al.
Publicado: (2015)

Reduction of Severity of Recurrent Psychotic Episode by Sustained Treatment with Aripiprazole in a Schizophrenic Patient with Dopamine Supersensitivity: A Case Report
por: Tadokoro, Shigenori, et al.
Publicado: (2017)

S37. STATE-DEPENDENT EFFECTS OF D2 PARTIAL AGONIST ARIPIPRAZOLE ON DOPAMINE NEURON ACTIVITY IN THE MAM NEURODEVELOPMENTAL MODEL OF SCHIZOPHRENIA
por: Sonnenschein, Susan, et al.
Publicado: (2018)

Identifying dopamine supersensitivity through a randomized controlled study of switching to aripiprazole from other antipsychotic agents in patients with schizophrenia
por: Ma, Chia-Hao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rei897orn3avearjg5lb9dlmcj